Alper Sevinç

2.4k total citations
125 papers, 1.6k citations indexed

About

Alper Sevinç is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Alper Sevinç has authored 125 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 49 papers in Oncology and 24 papers in Surgery. Recurrent topics in Alper Sevinç's work include Cancer Treatment and Pharmacology (13 papers), Gastrointestinal Tumor Research and Treatment (11 papers) and Gastric Cancer Management and Outcomes (9 papers). Alper Sevinç is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Gastrointestinal Tumor Research and Treatment (11 papers) and Gastric Cancer Management and Outcomes (9 papers). Alper Sevinç collaborates with scholars based in Türkiye, Switzerland and Saudi Arabia. Alper Sevinç's co-authors include Celalettin Camcı, Süleyman Buyukberber, Nimet Ovayolu, Özlem Ovayolu, Ramazan Sarı, Hacı Mehmet Türk, Mehmet Kalender, Celaletdin Camcı, Seda Pehlivan and Mehmet Ateş and has published in prestigious journals such as Journal of Clinical Oncology, Gynecologic Oncology and BMJ Open.

In The Last Decade

Alper Sevinç

121 papers receiving 1.5k citations

Peers

Alper Sevinç
Betty Wong Canada
Beth Barber United States
Liyue Tong United States
Jeffrey L. Berenberg United States
Alper Sevinç
Citations per year, relative to Alper Sevinç Alper Sevinç (= 1×) peers Ahmet Alacacıoğlu

Countries citing papers authored by Alper Sevinç

Since Specialization
Citations

This map shows the geographic impact of Alper Sevinç's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alper Sevinç with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alper Sevinç more than expected).

Fields of papers citing papers by Alper Sevinç

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alper Sevinç. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alper Sevinç. The network helps show where Alper Sevinç may publish in the future.

Co-authorship network of co-authors of Alper Sevinç

This figure shows the co-authorship network connecting the top 25 collaborators of Alper Sevinç. A scholar is included among the top collaborators of Alper Sevinç based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alper Sevinç. Alper Sevinç is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oruç, Zeynep, Kaplan Ma, Çağlayan Geredeli, et al.. (2020). Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.. PubMed. 24(2). 1876–1883. 2 indexed citations
2.
Dane, Faysal, Şuayib Yalçın, Mustafa Beneklı, et al.. (2020). Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study. BMJ Open. 10(3). e027665–e027665. 9 indexed citations
3.
Yalçın, Şuayib, Ramazan Yıldız, Faysal Dane, et al.. (2018). A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study. OncoTargets and Therapy. Volume 11. 1223–1228. 2 indexed citations
4.
Çiçek, Hülya, et al.. (2017). Vitamin D receptor polymorphisms and related biochemical parameters in various cancer species. Turkish Journal of Biochemistry. 42(2). 161–168. 5 indexed citations
5.
Gümüş, Mahmut, Ahmet Bılıcı, Hatice Odabaş, et al.. (2016). Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors. World Journal of Urology. 35(7). 1103–1110. 8 indexed citations
6.
Sevinç, Alper, et al.. (2014). Pain Management With Intrathecal Clonidine In Colon Cancer Patient With Opioid Hyperalgesia: Case Presentation. Ağrı - The Journal of The Turkish Society of Algology. 26(2). 93–96. 6 indexed citations
7.
Bozkurt, Oktay, Aydın Çiltaş, Kaplan Ma, et al.. (2014). Efficacy and Safety of Raltitrexed Combinations with Uracil-Tegafur or Mitomycin C as Salvage Treatment in Advanced Colorectal Cancer Patients: A Multicenter Study of Anatolian Society of Medical Oncology (ASMO). Asian Pacific Journal of Cancer Prevention. 15(4). 1845–1849. 5 indexed citations
8.
Kefeli, Umut, Murat Akyol, Ramazan Yıldız, et al.. (2013). Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience.. PubMed. 60(124). 647–52. 4 indexed citations
9.
Akıncı, Muhammed Bülent, Ali̇ İnal, Hatice Odabaş, et al.. (2013). Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study.. PubMed. 18(2). 314–20. 2 indexed citations
10.
Çetin, Bülent, Mustafa Beneklı, Faysal Dane, et al.. (2013). Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience. Breast Care. 8(1). 67–70. 18 indexed citations
12.
Pehlivan, Seda, Özlem Ovayolu, Nimet Ovayolu, Alper Sevinç, & Celalettin Camcı. (2011). Relationship between hopelessness, loneliness, and perceived social support from family in Turkish patients with cancer. Supportive Care in Cancer. 20(4). 733–739. 80 indexed citations
13.
Pehlivan, Yavuz, İbrahim Halil Türkbeyler, Alper Sevinç, et al.. (2011). Possible anti-metastatic effect of Iloprost in a patient with systemic sclerosis with lung cancer: a case study. Rheumatology International. 32(5). 1437–1441. 6 indexed citations
14.
Kaya, Ali, Süleyman Buyukberber, Faysal Dane, et al.. (2010). Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer.. PubMed. 96(3). 400–4. 2 indexed citations
15.
Kalender, Mehmet, et al.. (2010). Leech Therapy for Symptomatic Relief of Cancer Pain. Pain Medicine. 11(3). 443–445. 36 indexed citations
16.
Helvacı, Mehmet Rami, Hasan Kaya, Alper Sevinç, & Celaletdin Camcı. (2009). BODY WEIGHT AND WHITE COAT HYPERTENSION. Pakistan Journal of Medical Sciences. 25(6). 916–921. 26 indexed citations
18.
Pehlivan, Seda, et al.. (2008). The Use of Complementary Therapies in Cancer Patients. American Journal of Clinical Oncology. 31(6). 589–594. 26 indexed citations
19.
Sevinç, Alper, Celalettin Camcı, Hacı Mehmet Türk, & Süleyman Buyukberber. (2003). How to Interpret Serum CA 125 Levels in Patients with Serosal Involvement? A Clinical Dilemma. Oncology. 65(1). 1–6. 59 indexed citations
20.
Sarı, Ramazan, Alper Sevinç, Ismet Aydogdu, & Melih Karıncaoğlu. (2001). Upper and lower gastrointestinal endoscopical investigation in elderly patients with iron deficiency anaemia. PubMed. 31(4). 327–332. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026